8-K - Precigen, Inc. | StockGist

Current Report Details

Event Type

Material Agreement+3 More

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

. Entry into a Material Definitive Agreement. Pharmakon Loan Agreement On September 3, 2025 (the “ Closing Date ”), Precigen, Inc . (“ we ” or the “ Company ”)

Material Agreement

$125.0M$100.0M$25.0M

Source Document

2.03

. Item 7.01. Regulation FD Disclosure. A copy of Precigen’s press release announcing the financing transaction described in this Report is furnished as Exhibit

Financing

7.01

. This information, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor sh

Regulation Fd

9.01

. Financial Statements and Exhibits. d) Exhibits. Exhibit No. Description 10.1† Loan Agreement dated as of September 3, 2025, among Precigen, Inc., the guaranto

Exhibits Only

$125.0M

Source Document

Exhibits (3)

10.1

EXHIBIT 10.1

8-K

FORM 8-K

99.1

EXHIBIT 99.1